Company Analysis

Femasys Inc. (FEMY)

Nasdaq: FEMY · Surgical & Medical Instruments & Apparatus · Suwanee, GA · filing with the SEC since 2005
Grade4.2
◀ Past 3.8● Present 2.7▶ Future 6.6
1 est.

Who runs Femasys Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Lee-Sepsick Kathy
Chief Executive Officer. First filing Jun 2021, latest Aug 11, 2026, 1 filing in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
24 people on the record since 2021
Officerssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Lee-Sepsick KathyChief Executive OfficerJun 2021Aug 11, 2026none
Elefant DovChief Financial OfficerMar 2022Aug 11, 2026none
Canning John CharlesChief Operating OfficerApr 2026Aug 11, 2026none
Mifek Jeffrey GeraldChief Clinical-Medical AffairsAug 2026Aug 11, 2026none
Sipos Jeremy AlexanderChief Technology OfficerFeb 2026Aug 11, 2026none
Directorssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Moorhead John Hunnewell JrdirectorNov 2026Nov 5, 2026none
Eichenbaum Kenneth D.directorMar 2026Aug 11, 2026none
Larsen CharlesdirectorJun 2021Aug 11, 2026none
Milnes AlistairdirectorJun 2023Aug 11, 2026none
Uzialko Edward RdirectorJun 2021Aug 11, 2026none
Silverman JoshuadirectorNov 2023Mar 18, 2026none
Owners of more than 10% of a classsales are open-market, Nov 5, 2025 to Nov 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Pharmacyte Biotech, Inc.10% ownerNov 2023Mar 18, 2026none
Earlier names on the record13, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton FEMY · research, not advice